These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22631054)

  • 1. Future immunosuppression in organ transplantation: treating the innate immune system of the deceased donor--start tomorrow.
    Land WG
    Exp Clin Transplant; 2012 Jun; 10(3):195-208. PubMed ID: 22631054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):88-102. PubMed ID: 22000661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic dendritic cells and their role in transplantation.
    Ezzelarab M; Thomson AW
    Semin Immunol; 2011 Aug; 23(4):252-63. PubMed ID: 21741270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Therapy in Solid Organ Transplantation.
    Cai S; Chandraker A
    Curr Gene Ther; 2019; 19(2):71-80. PubMed ID: 31161989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1-induced tolerogenic dendritic cells combined with apoptotic lymphocytes prolong liver allograft survival.
    Peng Y; Ye Y; Jia J; He Y; Yang Z; Zhu X; Huang H; Wang W; Geng L; Yin S; Zhou L; Zheng S
    Int Immunopharmacol; 2018 Dec; 65():470-482. PubMed ID: 30390594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New directions for induction immunosuppression strategy in solid organ transplantation.
    Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
    Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The innate natural killer cells in transplant rejection and tolerance induction.
    Kroemer A; Edtinger K; Li XC
    Curr Opin Organ Transplant; 2008 Aug; 13(4):339-43. PubMed ID: 18685327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infections, alloimmunity, and transplantation tolerance.
    Ahmed EB; Daniels M; Alegre ML; Chong AS
    Transplant Rev (Orlando); 2011 Jan; 25(1):27-35. PubMed ID: 21126661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of alloimmunity of the intestinal graft.
    Trentadue G; Dijkstra G
    Curr Opin Organ Transplant; 2015 Jun; 20(3):286-94. PubMed ID: 25944233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells.
    Huang YL; Wang YZ; Chen JB; Wang F; Kang XP; Xia JJ; Lan TS; Xie BY; Ekberg H; Wang XM; Qi ZQ
    Scand J Immunol; 2011 Feb; 73(2):91-101. PubMed ID: 21198749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The innate immune response to allotransplants: mechanisms and therapeutic potentials.
    Ochando J; Ordikhani F; Boros P; Jordan S
    Cell Mol Immunol; 2019 Apr; 16(4):350-356. PubMed ID: 30804476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant immunology for non-immunologist.
    Heeger PS; Dinavahi R
    Mt Sinai J Med; 2012; 79(3):376-87. PubMed ID: 22678861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the Art: Role of the Dendritic Cell in Induction of Allograft Tolerance.
    Rosen SJ; Harris PE; Hardy MA
    Transplantation; 2018 Oct; 102(10):1603-1613. PubMed ID: 29677072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.